The New Colossus: The Digest’s 2016 Multi-Slide Guide to Amyris

In California, Amyris reported a Q2 net loss of $13.8M on revenues of $9,6M, up from $7.8M in Q2 2015. Revenues rose 27% from the corresponding period in 2015 primarily driven by the shipment of a new novel fragrance product, as well as Neossance Squalane sales. At the same time, Amyris, which has recorded $18.4M in revenues for the first half, re-affirmed guidance for the year that it would reach $90M in annual sales and positive cash flow from operations in 2017.

We reported on Amyris’ progress most recently in “The New Colossus aims to unlock its Golden Door”. The company’s most recent corporate overview is here below.